Tag: Cancer: Prostate
ADT + Pelvic Lymph Node Radiation Improves Prostate Cancer Outcomes
Five-year freedom from progression rate higher for those receiving short-term ADT and PLNRT in addition to salvage PBRT
AE Risk Examined for Abiraterone, Enzalutamide in Prostate Cancer
Risk for metabolic or cardiovascular adverse events increased for men receiving abiraterone or enzalutamide for advanced disease
KangDuo Surgical Robot-01 System Feasible for Radical Prostatectomy
Evaluation shows safety and effectiveness for the management of localized prostate cancer
AUA: Pandemic Disruptions Impacted One in Four Prostate, Bladder Cancer Patients
Changes, delays, and cancellation of cancer treatment and ancillary care reported
Orteronel Misses Goal in Metastatic Hormone-Sensitive Prostate Cancer
Significant improvement seen in progression-free survival, but not overall survival, with addition of orteronel to androgen deprivation therapy
Impact of Method for Assessing Occupational Pesticide Exposure Examined
Method for assessing occupational pesticide exposure seems not to influence risk estimates for prostate cancer, NHL, Parkinson disease
Prostate Cancer Biopsy, Diagnoses Down During the Pandemic
However, there were no statistically significant changes in rates by race
Exercise May Cut Worry of Active Surveillance for Prostate Cancer
Supervised high-intensity interval training program tied to reductions in anxiety, fear of progression, hormonal symptoms, stress, fatigue
Adding Darolutamide Ups Survival in Metastatic Prostate Cancer
Risk for death lower with darolutamide versus placebo, combined with androgen-deprivation therapy and docetaxel
Less Toxicity Seen With MRI-Guided SBRT for Prostate Cancer
Rate of acute grade ≥2 genitourinary toxicity lower with MRI guidance versus CT guidance for SBRT in men with localized prostate cancer
